• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发用于治疗肝脏疾病的天然海洋产品。

Developing natural marine products for treating liver diseases.

作者信息

Wei Qian, Guo Jin-Sheng

机构信息

Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

出版信息

World J Clin Cases. 2022 Mar 16;10(8):2369-2381. doi: 10.12998/wjcc.v10.i8.2369.

DOI:10.12998/wjcc.v10.i8.2369
PMID:35434070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8968605/
Abstract

In recent years, marine-derived bioactive compounds have gained increasing attention because of their higher biodiversity land-derived compounds. A number of marine-derived compounds are proven to improve lipid metabolism, modulate the gut microbiota, and possess anti-inflammatory, antioxidant, antibacterial, antiviral, and antitumor activities. With the increasing understanding of the molecular landscape underlying the pathogenesis of chronic liver diseases, interest has spiked in developing new therapeutic drugs and medicine food homology from marine sources for the prevention and treatment of liver diseases.

摘要

近年来,海洋来源的生物活性化合物因其比陆地来源的化合物具有更高的生物多样性而受到越来越多的关注。许多海洋来源的化合物已被证明可改善脂质代谢、调节肠道微生物群,并具有抗炎、抗氧化、抗菌、抗病毒和抗肿瘤活性。随着对慢性肝病发病机制背后分子格局的认识不断加深,人们对开发来自海洋来源的新型治疗药物和药食同源物质以预防和治疗肝病的兴趣激增。

相似文献

1
Developing natural marine products for treating liver diseases.开发用于治疗肝脏疾病的天然海洋产品。
World J Clin Cases. 2022 Mar 16;10(8):2369-2381. doi: 10.12998/wjcc.v10.i8.2369.
2
Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.药用目的:海洋生物来源的生物活性代谢物。
Mini Rev Med Chem. 2019;19(2):138-164. doi: 10.2174/1389557517666170927113143.
3
Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi.潜在的药理学资源:来自海洋真菌的天然生物活性化合物
Mar Drugs. 2016 Apr 22;14(4):76. doi: 10.3390/md14040076.
4
Pharmaceutically active secondary metabolites of marine actinobacteria.海洋放线菌的具有药用活性的次生代谢产物。
Microbiol Res. 2014 Apr;169(4):262-78. doi: 10.1016/j.micres.2013.07.014. Epub 2013 Aug 16.
5
Exploring marine resources for bioactive compounds.探索海洋资源以获取生物活性化合物。
Planta Med. 2014 Sep;80(14):1234-46. doi: 10.1055/s-0034-1383001. Epub 2014 Sep 9.
6
Are There Any Other Compounds Isolated From Dermacoccus spp at All?是否从皮球菌属中分离出了其他任何化合物?
Curr Microbiol. 2017 Jan;74(1):132-144. doi: 10.1007/s00284-016-1152-3. Epub 2016 Oct 26.
7
Marine natural products and related compounds in clinical and advanced preclinical trials.处于临床和临床前高级试验阶段的海洋天然产物及相关化合物。
J Nat Prod. 2004 Aug;67(8):1216-38. doi: 10.1021/np040031y.
8
From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds.从海洋起源到治疗应用:海洋藻类衍生化合物的抗肿瘤潜力
Front Pharmacol. 2018 Aug 6;9:777. doi: 10.3389/fphar.2018.00777. eCollection 2018.
9
Marine-Derived Bioactive Peptides for Biomedical Sectors: A Review.用于生物医学领域的海洋源生物活性肽:综述
Protein Pept Lett. 2017;24(2):109-117. doi: 10.2174/0929866523666160802155347.
10
Marine natural products as source of new drugs: a patent review (2015-2018).海洋天然产物作为新药来源:专利审查(2015-2018 年)。
Expert Opin Ther Pat. 2019 Apr;29(4):283-309. doi: 10.1080/13543776.2019.1598972. Epub 2019 Apr 3.

引用本文的文献

1
Enhanced In Vitro Efficacy of Verbascoside in Suppressing Hepatic Stellate Cell Activation via ROS Scavenging with Reverse Microemulsion.毛蕊花糖苷通过反相微乳剂清除活性氧增强体外抑制肝星状细胞激活的功效。
Antioxidants (Basel). 2024 Jul 27;13(8):907. doi: 10.3390/antiox13080907.
2
Actinoquinazolinone, a New Quinazolinone Derivative from a Marine Bacterium sp. CNQ-617, Suppresses the Motility of Gastric Cancer Cells.放线喹唑啉酮,一种源自海洋细菌菌株CNQ - 617的新型喹唑啉酮衍生物,可抑制胃癌细胞的运动。
Mar Drugs. 2023 Sep 13;21(9):489. doi: 10.3390/md21090489.
3
Editorial: Biologically active products as therapeutic options for the treatment of cardiovascular diseases related to liver injury.社论:生物活性产品作为治疗与肝损伤相关心血管疾病的治疗选择。
Front Pharmacol. 2022 Oct 24;13:1041020. doi: 10.3389/fphar.2022.1041020. eCollection 2022.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent.虾青素在肝脏健康与疾病中的作用:一种潜在的治疗剂。
Drug Des Devel Ther. 2020 Jun 9;14:2275-2285. doi: 10.2147/DDDT.S230749. eCollection 2020.
3
Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge () Species in Green Synthesized Silver Nanoparticles Assisted by in Silico Modeling and Metabolic Profiling.基于计算机模拟和代谢谱分析的红海海绵()物种中绿色合成银纳米粒子对丙型肝炎病毒 NS3 蛋白酶和解旋酶抑制剂的研究
Int J Nanomedicine. 2020 May 12;15:3377-3389. doi: 10.2147/IJN.S233766. eCollection 2020.
4
Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends.药物性肝损伤(DILI)潜在风险分层的新型生物标志物:对当前趋势的叙述性观点
Medicine (Baltimore). 2019 Dec;98(50):e18322. doi: 10.1097/MD.0000000000018322.
5
Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis.含硫天然化合物:抗肝纤维化的另一种治疗策略。
Cells. 2019 Oct 30;8(11):0. doi: 10.3390/cells8111356.
6
Anti-Metabolic Syndrome Effects of Fucoidan from via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling.褐藻糖胶通过活性氧介导的 JNK、Akt 和 AMPK 信号通路调节对代谢综合征的防治作用。
Molecules. 2019 Sep 12;24(18):3319. doi: 10.3390/molecules24183319.
7
Identification and Characterization of a Novel Protein ASP-3 Purified from and Its Antitumor Mechanism.从 中分离纯化的一种新型蛋白 ASP-3 的鉴定及其抗肿瘤机制。
Mar Drugs. 2019 Sep 9;17(9):528. doi: 10.3390/md17090528.
8
Bioactivities and Extract Dereplication of Isolated From Marine Sponges.从海洋海绵中分离出的生物活性及提取物的去重复分析
Front Microbiol. 2019 Apr 9;10:727. doi: 10.3389/fmicb.2019.00727. eCollection 2019.
9
Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者中二甲双胍的肝脏暴露情况。
Br J Clin Pharmacol. 2019 Aug;85(8):1761-1770. doi: 10.1111/bcp.13962. Epub 2019 Jun 18.
10
Comparative Transcriptome Analyses Provide Potential Insights into the Molecular Mechanisms of Astaxanthin in the Protection against Alcoholic Liver Disease in Mice.比较转录组分析为虾青素防治酒精性肝病的分子机制提供了潜在的见解。
Mar Drugs. 2019 Mar 19;17(3):181. doi: 10.3390/md17030181.